Matches in DBpedia 2016-04 for { <http://citation.dbpedia.org/hash/580c9046b3f195a8eb9394e017bf1015e8fe4b1de79636d8eebb4d8636437497> ?p ?o }
Showing triples 1 to 13 of
13
with 100 triples per page.
- 580c9046b3f195a8eb9394e017bf1015e8fe4b1de79636d8eebb4d8636437497 first "M".
- 580c9046b3f195a8eb9394e017bf1015e8fe4b1de79636d8eebb4d8636437497 first2 "B".
- 580c9046b3f195a8eb9394e017bf1015e8fe4b1de79636d8eebb4d8636437497 first3 "M".
- 580c9046b3f195a8eb9394e017bf1015e8fe4b1de79636d8eebb4d8636437497 isCitedBy Ebastine.
- 580c9046b3f195a8eb9394e017bf1015e8fe4b1de79636d8eebb4d8636437497 issue "4".
- 580c9046b3f195a8eb9394e017bf1015e8fe4b1de79636d8eebb4d8636437497 journal "J Invest Allergol Clin Immunol".
- 580c9046b3f195a8eb9394e017bf1015e8fe4b1de79636d8eebb4d8636437497 last "Salvà".
- 580c9046b3f195a8eb9394e017bf1015e8fe4b1de79636d8eebb4d8636437497 last2 "Carreño".
- 580c9046b3f195a8eb9394e017bf1015e8fe4b1de79636d8eebb4d8636437497 last3 "Pintos".
- 580c9046b3f195a8eb9394e017bf1015e8fe4b1de79636d8eebb4d8636437497 page "S5".
- 580c9046b3f195a8eb9394e017bf1015e8fe4b1de79636d8eebb4d8636437497 title "Phase I, single dose, open label, randomized, crossover bioequivalence studies of ebastine 10 mg and 20 mg regular tablets vs 10 and 20 mg fast-dissolving tablets in healthy male volunteers".
- 580c9046b3f195a8eb9394e017bf1015e8fe4b1de79636d8eebb4d8636437497 volume "14".
- 580c9046b3f195a8eb9394e017bf1015e8fe4b1de79636d8eebb4d8636437497 year "2004".